Synexus agrees to private sale
Management of publicly-traded Synexus have agreed to the £18.1m (€25.7m) sale of the company to a private equity firm that has promised to fund its global expansion ventures.
Archives for November 12, 2007
Tripos lands Schering-Plough deal
Tripos Discovery Research (TDR) has risen from the ashes surrounding the liquidation of its previous owners Tripos, Inc. to land a 'library enrichment' deal with Schering-Plough.
AstraZeneca axes packaging plant
AstraZeneca's axe has made its latest appearance in South Africa, with the sale of a packaging plant and the formation of an outsourcing deal with its new owners.
$60m expansion for mystery pharma
Swedish construction firm Skanska today announced that it has been awarded a multi-million dollar contract to expand a pharmaceutical facility in the US, though the company is keeping the identity of its client close to its chest.
China CRO attracts $30m US investment
China's second largest contract research organisation (CRO) ShangPharma has attracted $30m (€21m) from US private investment firm TPG as the Asian pharma market continues to simmer.
Hefty price hike for BASF excipients
German chemicals firm BASF has announced a major price hike across its range of pharmaceutical excipients, upping price tags by as much as 9 per cent.
New drug safety model unveiled as Merck shells out for Vioxx
A new 3D model of the human liver that even has its own blood supply could pump new life into drug safety tests by predicting problems earlier and cut down on animal experiments.